Literature DB >> 11693436

Macrophages: a crucial reservoir for human immunodeficiency virus in the body.

E Balestra1, C F Perno, S Aquaro, S Panti, A Bertoli, M Piacentini, F Forbici, R D'Arrigo, R Calió, E Garaci.   

Abstract

The replication of Human Immunodeficiency Virus (HIV) in cells of macrophage lineage represents a key pathogenetic event of the neurological damages typically found during the course of this disease. Macrophages are persistently infected cells and thus not susceptible to the cytophatic effect typical of infected activated CD4-lymphocytes. The resistance of macrophages to HIV infection is at least in part mediated by the autocrine production of the nerve growth factor (NGF), a neurokine able to sustain the survival of some cells of bone marrow origin, including monocyte-derived macrophages. This anti-apoptotic effect of NGF in HIV-infected macrophages can be even more relevant at the central nervous system level, where many cells are able to physiologically produce NGF, thus further increasing the survival of macrophages infected by HIV, and enhancing the damages that these cells may induce upon bystander neurons. The proapoptotic effect of soluble factors released by HIV-infected macrophages may heavily affect the survival and functions also of astrocytes, that in turn become unable to sustain neuronal homeostasis. Taken together, this information supports the importance of therapeutic attempts aimed at attacking virus replication in infected macrophages and/or to selectively eliminate these chronically infected and persistently virus-producing cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11693436

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  11 in total

Review 1.  Antiretroviral therapy in macrophages: implication for HIV eradication.

Authors:  Christina Gavegnano; Raymond F Schinazi
Journal:  Antivir Chem Chemother       Date:  2009-10-19

2.  Impact on genetic networks in human macrophages by a CCR5 strain of human immunodeficiency virus type 1.

Authors:  Carter R Coberley; James J Kohler; Joseph N Brown; Joseph T Oshier; Henry V Baker; Michael P Popp; John W Sleasman; Maureen M Goodenow
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

3.  Cellular pharmacology and potency of HIV-1 nucleoside analogs in primary human macrophages.

Authors:  Christina Gavegnano; Mervi A Detorio; Leda Bassit; Selwyn J Hurwitz; Thomas W North; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2012-12-21       Impact factor: 5.191

4.  The Impact of Macrophage Nucleotide Pools on HIV-1 Reverse Transcription, Viral Replication, and the Development of Novel Antiviral Agents.

Authors:  Christina Gavegnano; Edward M Kennedy; Baek Kim; Raymond F Schinazi
Journal:  Mol Biol Int       Date:  2012-07-01

5.  NFAT5 regulates HIV-1 in primary monocytes via a highly conserved long terminal repeat site.

Authors:  Shahin Ranjbar; Alla V Tsytsykova; Sang-Kyung Lee; Ricardo Rajsbaum; James V Falvo; Judy Lieberman; Premlata Shankar; Anne E Goldfeld
Journal:  PLoS Pathog       Date:  2006-12       Impact factor: 6.823

6.  Measuring glutathione redox potential of HIV-1-infected macrophages.

Authors:  Ashima Bhaskar; MohamedHusen Munshi; Sohrab Zafar Khan; Sadaf Fatima; Rahul Arya; Shahid Jameel; Amit Singh
Journal:  J Biol Chem       Date:  2014-11-18       Impact factor: 5.157

7.  HIV‑1 downregulates the expression and phosphorylation of receptor tyrosine kinase by targeting the NF‑κB pathway.

Authors:  Tingting Feng; Jianhe Gan; Ailan Qin; Xiaoping Huang; Nanping Wu; Hua Hu; Hangping Yao
Journal:  Mol Med Rep       Date:  2016-07-08       Impact factor: 2.952

8.  Apoptosis resistance in HIV-1 persistently-infected cells is independent of active viral replication and involves modulation of the apoptotic mitochondrial pathway.

Authors:  Pablo N Fernández Larrosa; Diego O Croci; Diego A Riva; Mariel Bibini; Renata Luzzi; Mónica Saracco; Susana E Mersich; Gabriel A Rabinovich; Liliana Martínez Peralta
Journal:  Retrovirology       Date:  2008-02-08       Impact factor: 4.602

9.  Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages.

Authors:  Matteo Surdo; Emanuela Balestra; Patrizia Saccomandi; Fabiola Di Santo; Marco Montano; Domenico Di Carlo; Loredana Sarmati; Stefano Aquaro; Massimo Andreoni; Valentina Svicher; Carlo Federico Perno; Francesca Ceccherini-Silberstein
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

10.  HIV-1 promonocytic and lymphoid cell lines: an in vitro model of in vivo mitochondrial and apoptotic lesion.

Authors:  Constanza Morén; Ingrid González-Casacuberta; Carmen Álvarez-Fernández; Maria Bañó; Marc Catalán-Garcia; Mariona Guitart-Mampel; Diana Luz Juárez-Flores; Ester Tobías; José Milisenda; Francesc Cardellach; Josep Maria Gatell; Sonsoles Sánchez-Palomino; Glòria Garrabou
Journal:  J Cell Mol Med       Date:  2016-10-18       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.